{"id":"W4411017374","doi":"10.1016/j.esmoop.2025.105286","title":"Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancer","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; EMD Serono; Genentech; National Cancer Institute; Gilead Sciences; Servier; Sociedad Española de Oncología Médica; Astellas Pharma; University of Toronto; Canadian Cancer Society; Seagen; PTC Therapeutics; Celgene; Conquer Cancer Foundation; Princess Margaret Cancer Foundation; Breast Cancer Research Foundation; Sanofi; GlaxoSmithKline; Pfizer; Symphogen; American Society of Clinical Oncology; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Canadian Association of Medical Oncologists; Susan G. Komen for the Cure; Amgen","keywords":"Epigenomics; Identification (biology); Breast cancer; Computational biology; Cancer; Stage (stratigraphy); DNA methylation; genomic DNA; Biology; Oncology; DNA; Medicine; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001234589,0.000314788,0.0002701039,0.0006763915,0.0001473699,0.0004327467,0.0003677285,0.0003401385,0.0009192756],"category_scores_gemma":[0.001978651,0.0002270364,0.0002008344,0.0004530043,0.0002654623,0.0002011251,0.0004336966,0.0003306161,0.0002067453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002237316,"about_ca_system_score_gemma":0.000271501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007349566,"about_ca_topic_score_gemma":0.002142622,"domain_scores_codex":[0.9992591,0.0001999983,0.00004345601,0.0002729748,0.0001647116,0.00005978216],"domain_scores_gemma":[0.9986804,0.0003555641,0.0005123393,0.0001513043,0.0001923502,0.0001080536],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001203345,0.0001836683,0.8986753,0.0001399303,0.000338975,0.0001109449,0.0001543987,0.0009788654,0.07340337,0.0001064587,0.0002873271,0.02441748],"study_design_scores_gemma":[0.00003755109,0.00101531,0.9708771,0.00001737717,0.0002160692,0.001096912,0.00007995436,0.002593118,0.02293187,0.0001407778,0.0009757905,0.00001816862],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949824,0.0008780591,0.002910901,0.00004190876,0.000008081032,0.00004600406,0.0006806107,0.00003936475,0.0004126292],"genre_scores_gemma":[0.9965972,0.0001328797,0.00240261,0.00004418667,0.000008043423,0.000035152,0.0005386905,0.00000469294,0.0002364153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001234589,"threshold_uncertainty_score":0.006529212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04882968378360836,"score_gpt":0.3169911366718874,"score_spread":0.268161452888279,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}